耐药性疟疾的演变。
The evolution of drug-resistant malaria.
机构信息
Howard Hughes Medical Institute, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
出版信息
Trans R Soc Trop Med Hyg. 2009 Apr;103 Suppl 1(Suppl 1):S11-4. doi: 10.1016/j.trstmh.2008.11.002. Epub 2008 Dec 12.
Abstract
Molecular epidemiological investigations have uncovered the patterns of emergence and global spread of Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine. Malaria parasites highly resistant to chloroquine and pyrimethamine spread from Asian origins to Africa, at great cost to human health and life. If artemisinin-resistant falciparum malaria follows the same pattern, renewed efforts to eliminate and eradicate malaria will be gravely threatened. This paper, adapted from a talk given in honour of Professor Malcolm Molyneux in Liverpool in September 2008, reviews the rise and fall of clinically important forms of drug-resistant falciparum malaria and considers how lessons learned from studying the evolution of drug-resistant malaria can be applied to efforts to prevent and deter resistance.
摘要
分子流行病学调查揭示了疟原虫对氯喹和磺胺多辛-乙胺嘧啶耐药性的出现和全球传播模式。对氯喹和乙胺嘧啶高度耐药的疟原虫从亚洲起源传播到非洲，给人类健康和生命带来了巨大的代价。如果青蒿素耐药性恶性疟按照同样的模式发展，消除和根除疟疾的努力将受到严重威胁。本文改编自 2008 年 9 月在利物浦为纪念马尔科姆·莫利纽克斯教授而作的演讲，回顾了临床上重要的耐药性恶性疟的兴衰，并探讨了从研究耐药性疟疾的演变中吸取的经验教训如何应用于预防和遏制耐药性的努力。
相似文献
1
The evolution of drug-resistant malaria.耐药性疟疾的演变。
Trans R Soc Trop Med Hyg. 2009 Apr;103 Suppl 1(Suppl 1):S11-4. doi: 10.1016/j.trstmh.2008.11.002. Epub 2008 Dec 12.
2
Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.恶性疟原虫耐药性标志物的分子监测显示，在卢旺达疟疾传播强度不同的两个地点，氯喹敏感性部分恢复，但磺胺多辛-乙胺嘧啶耐药性持续存在。
Acta Trop. 2016 Dec;164:329-336. doi: 10.1016/j.actatropica.2016.09.008. Epub 2016 Sep 17.
3
Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next?恶性疟原虫对乙胺嘧啶-磺胺多辛的耐药性：接下来该怎么办？
Trends Parasitol. 2001 Dec;17(12):582-8. doi: 10.1016/s1471-4922(01)02085-2.
4
5
Molecular analysis of chloroquine and sulfadoxine-pyrimethamine resistance-associated alleles in Plasmodium falciparum isolates from Nicaragua.尼加拉瓜恶性疟原虫分离株中氯喹和磺胺多辛-乙胺嘧啶抗性相关等位基因的分子分析
Am J Trop Med Hyg. 2014 May;90(5):840-5. doi: 10.4269/ajtmh.13-0214. Epub 2014 Mar 10.
6
The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector.氯喹和乙胺嘧啶/磺胺多辛对疟原虫物种感染蚊媒的不同影响。
Am J Trop Med Hyg. 1998 Feb;58(2):176-82. doi: 10.4269/ajtmh.1998.58.176.
7
Chloroquine and sulphadoxine-pyrimethamine sensitivity of Plasmodium falciparum parasites in a Brazilian endemic area.巴西流行地区恶性疟原虫对氯喹和磺胺多辛-乙胺嘧啶的敏感性。
Malar J. 2009 Jul 14;8:156. doi: 10.1186/1475-2875-8-156.
8
Efficacy of sulfadoxine-pyrimethamine in chloroquine resistant falciparum malaria in Bombay.乙胺嘧啶-磺胺多辛治疗孟买氯喹耐药恶性疟的疗效
J Assoc Physicians India. 1996 Oct;44(10):683-5.
9
Mapping the spread of malaria drug resistance.绘制疟疾耐药性的传播图谱。
PLoS Med. 2009 Apr 14;6(4):e1000054. doi: 10.1371/journal.pmed.1000054.
10
Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance.马里社区乙胺嘧啶-磺胺多辛的使用情况及恶性疟原虫耐药基因型的流行率：一种抗耐药性的模型
Am J Trop Med Hyg. 1996 Nov;55(5):467-71. doi: 10.4269/ajtmh.1996.55.467.
引用本文的文献
1
Prevalence and genetic diversity of polymorphisms in , and genes of in southern Côte d'Ivoire.科特迪瓦南部[某种疾病或研究对象]的[相关基因名称]、[相关基因名称]和[相关基因名称]基因多态性的患病率及遗传多样性
Malariaworld J. 2025 Jan 6;16:1. doi: 10.5281/zenodo.14604138. eCollection 2025.
2
Screening for antifolate and artemisinin resistance in dried-blood spots from three hospitals of Eritrea.对厄立特里亚三家医院干血斑中的抗叶酸和青蒿素耐药性进行筛查。
F1000Res. 2024 Jun 12;10:628. doi: 10.12688/f1000research.54195.3. eCollection 2021.
3
Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine and prevalence of molecular markers of anti-malarial drug resistance in children in Togo in 2021.2021 年多哥儿童青蒿琥酯-咯萘啶和双氢青蒿素-哌喹的疗效和抗疟药物耐药性分子标志物的流行情况。
Malar J. 2024 Apr 3;23(1):92. doi: 10.1186/s12936-024-04922-1.
4
Putative molecular markers of resistance to antimalarial drugs in malaria parasites from Ghana.加纳疟原虫中抗疟药物耐药性的假定分子标记
Front Epidemiol. 2024 Feb 15;4:1279835. doi: 10.3389/fepid.2024.1279835. eCollection 2024.
5
Increase of parasites carrying lumefantrine-tolerance molecular markers and lack of South East Asian artemisinin-resistance mutations in samples collected from 2013 to 2016 in Côte d'Ivoire.2013年至2016年在科特迪瓦采集的样本中，携带甲氟喹耐药分子标记的寄生虫数量增加，且未发现东南亚青蒿素耐药突变。
J Parasit Dis. 2024 Mar;48(1):59-66. doi: 10.1007/s12639-023-01640-4. Epub 2024 Jan 12.
6
Progress towards malaria elimination in the Greater Mekong Subregion: perspectives from the World Health Organization.大湄公河次区域消除疟疾进展：世界卫生组织的观点。
Malar J. 2024 Mar 1;23(1):64. doi: 10.1186/s12936-024-04851-z.
7
Plasmodium falciparum drug resistance-associated mutations in isolates from children living in endemic areas of Burkina Faso.布基纳法索流行地区儿童感染疟原虫的药物耐药相关突变。
Malar J. 2023 Jul 20;22(1):213. doi: 10.1186/s12936-023-04645-9.
8
How can the complex epidemiology of malaria in India impact its elimination?印度疟疾的复杂流行病学情况如何影响其消除工作？
Trends Parasitol. 2023 Jun;39(6):432-444. doi: 10.1016/j.pt.2023.03.006. Epub 2023 Apr 6.
9
Population Genomic Evidence of Adaptive Response during the Invasion History of Plasmodium falciparum in the Americas.人口基因组证据表明，在美洲恶性疟原虫的入侵历史中存在适应性反应。
Mol Biol Evol. 2023 May 2;40(5). doi: 10.1093/molbev/msad082.
10
Distinct pattern and prevalence of dihydropteroate synthase gene mutations in children with sickle cell anaemia and haemoglobin AA in Benin City, Nigeria: the impact of HbAA.在尼日利亚贝宁城，镰状细胞贫血和血红蛋白 AA 儿童中二氢叶酸还原酶基因突变的独特模式和流行率：HbAA 的影响。
Pan Afr Med J. 2022 Oct 13;43:80. doi: 10.11604/pamj.2022.43.80.34334. eCollection 2022.
本文引用的文献
1
Monitoring and deterring drug-resistant malaria in the era of combination therapy.联合治疗时代耐药性疟疾的监测与遏制
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):160-9.
2
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.世界抗疟耐药性网络（WARN）III：耐药疟疾的分子标记物
Malar J. 2007 Sep 6;6:121. doi: 10.1186/1475-2875-6-121.
3
Pfmdr1 and in vivo resistance to artesunate-mefloquine in falciparum malaria on the Cambodian-Thai border.Pfmdr1与柬埔寨-泰国边境恶性疟原虫对青蒿琥酯-甲氟喹的体内抗性
Am J Trop Med Hyg. 2007 Apr;76(4):641-7.
4
Return of chloroquine antimalarial efficacy in Malawi.氯喹在马拉维抗疟疗效的恢复
N Engl J Med. 2006 Nov 9;355(19):1959-66. doi: 10.1056/NEJMoa062032.
5
P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates.恶性疟原虫二氢叶酸还原酶和二氢蝶酸合酶突变：流行病学及其在临床抗叶酸药物耐药性中的作用
Drug Resist Updat. 1998;1(6):389-96. doi: 10.1016/s1368-7646(98)80014-9.
6
Intercontinental spread of pyrimethamine-resistant malaria.耐乙胺嘧啶疟疾的洲际传播。
Science. 2004 Aug 20;305(5687):1124. doi: 10.1126/science.1098876.
7
Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals.恶性疟原虫在坦噶尼喀对每周给药一次的乙胺嘧啶的耐药性。
Trans R Soc Trop Med Hyg. 1957 Nov;51(6):505-13. doi: 10.1016/0035-9203(57)90039-1.
8
Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi.马拉维停用氯喹后氯喹敏感型恶性疟原虫疟疾再度出现。
J Infect Dis. 2003 Jun 15;187(12):1870-5. doi: 10.1086/375419. Epub 2003 May 21.
9
Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America.南美洲恶性疟原虫耐药性突变的起源与传播
J Infect Dis. 2002 Oct 1;186(7):999-1006. doi: 10.1086/342946. Epub 2002 Sep 9.
10
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum.恶性疟原虫的遗传多样性与氯喹选择性清除
Nature. 2002 Jul 18;418(6895):320-3. doi: 10.1038/nature00813.
Zotero 插件